BioCardia, Inc.

Contributing Author

Recent Articles by BioCardia, Inc.

Apr-20	BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure BCDA +5.93% GlobeNewswire
Apr-02	BioCardia Files Request for Meeting With FDA to Discuss Accelerated Approval Pathway for CardiAMP System in Ischemic Heart Failure BCDA GlobeNewswire
Mar-24	BioCardia Reports 2025 Business Highlights and Financial Results BCDA GlobeNewswire
Mar-19	BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026 BCDA GlobeNewswire
Mar-17	BioCardia Announces Pre-Submission Approval Package for Helix Transendocardial Delivery Catheter Accepted by FDA BCDA GlobeNewswire
Mar-03	BioCardia Late Breaking Echocardiography Clinical Results from CardiAMP HF Trial Presented at Technology and Heart Failure Therapeutics (THT) BCDA -5.92% GlobeNewswire
Feb-10	BioCardia Files Pre-Submission for FDA Approval of Helix Transendocardial Delivery Catheter for Therapeutic and Diagnostic Agent Delivery to the Heart BCDA GlobeNewswire
Feb-03	BioCardia Announces Late Breaking Echocardiography Results from the CardiAMP HF Trial to be Presented at Technology and Heart Failure Therapeutics (THT) BCDA GlobeNewswire
Dec-16	BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA BCDA GlobeNewswire
Dec-03	BioCardia Announces Election of New Board Director, Marvin Slosman and Completion of Term for Outgoing Director, Dr. Richard Krasno BCDA GlobeNewswire
Dec-01	BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress BCDA GlobeNewswire
Nov-24	BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality BCDA GlobeNewswire
Nov-12	BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results BCDA GlobeNewswire
Nov-10	BioCardia Announces Henry Ford Health Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial BCDA GlobeNewswire
Nov-05	BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025 BCDA GlobeNewswire
Oct-30	BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial BCDA GlobeNewswire
Oct-02	BioCardia Regains Compliance with Nasdaq Listing Requirements BCDA GlobeNewswire
Sep-22	BioCardia Announces Positive Preliminary Clinical Consultation with Japan Pharmaceutical and Medical Device Agency on Cell Therapy for Ischemic Heart Failure BCDA GlobeNewswire
Sep-18	BioCardia Announces Pricing of Up To $12 Million Public Offering BCDA -23.78% GlobeNewswire
Sep-18	BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Top Line Data of Roll-in Cohort Show Improved Exercise Tolerance and Reduced Angina Episodes at Six-Month Primary Follow-up BCDA -23.78% GlobeNewswire
Sep-04	BioCardia CEO Peter Altman to Present at the H. C. Wainwright 27th Annual Global Investment Conference in New York City September 8-10, 2025 BCDA GlobeNewswire
Aug-13	BioCardia and CART-Tech Announce Exclusive Partnership to Develop and Commercialize Heart3D Fusion Imaging for Interventional Cardiology BCDA +6.90% GlobeNewswire
Aug-11	BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results BCDA -6.15% GlobeNewswire
Aug-06	BioCardia to Host Q2 2025 Corporate Update and Financial Results Conference Call on August 11, 2025 BCDA -5.52% GlobeNewswire
Aug-04	BioCardia Provides Update on Timing of Regulatory Activities Seeking FDA Approval and Japan PMDA Approval for CardiAMP Cell Therapy for Heart Failure and Helix Transendocardial Delivery Catheter BCDA -7.98% GlobeNewswire
Jul-24	BioCardia Submits Request for Clinical Data Review Meeting with Japan PMDA To Discuss Approval Pathway for CardiAMP Cell Therapy in Ischemic Heart Failure BCDA GlobeNewswire
Jul-16	Henry Ford Health Initiates Patient Enrollment for BioCardia's CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction BCDA GlobeNewswire
Jun-25	BioCardia Announces New United States Patent for Helix Biotherapeutic Delivery System BCDA GlobeNewswire
May-21	BioCardia to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21, 2025 BCDA GlobeNewswire
May-14	BioCardia Reports First Quarter 2025 Business Highlights and Financial Results BCDA -16.25% BCDA GlobeNewswire
May-09	BioCardia to Host Q1 2025 Corporate Update and Financial Results Conference Call on May 14, 2025 BCDA GlobeNewswire
May-06	BioCardia Initiates Patient Enrollment at University of Wisconsin at Madison for Ongoing CardiAMP HF II Pivotal Study BCDA GlobeNewswire
May-01	BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company's Lead Cell Therapy for Treatment of Heart Failure BCDA -9.24% GlobeNewswire

BioCardia, Inc.

Recent Articles by BioCardia, Inc.

Upgrade your Finviz experience